Diagnostic dilemmas in pulmonary mesenchymal tumors.
1/5 보강
Tumors of mesenchymal origin only rarely arise in the bronchopulmonary system and range from indolent neoplasms to highly malignant sarcomas.
APA
Weissferdt A (2026). Diagnostic dilemmas in pulmonary mesenchymal tumors.. Seminars in diagnostic pathology, 43(1), 150980. https://doi.org/10.1016/j.semdp.2025.150980
MLA
Weissferdt A. "Diagnostic dilemmas in pulmonary mesenchymal tumors.." Seminars in diagnostic pathology, vol. 43, no. 1, 2026, pp. 150980.
PMID
41478263 ↗
Abstract 한글 요약
Tumors of mesenchymal origin only rarely arise in the bronchopulmonary system and range from indolent neoplasms to highly malignant sarcomas. While many of these tumors occur more frequently outside of the thoracic cavity, there are some mesenchymal neoplasms that are unique to the lung, such as primary pulmonary myxoid sarcoma or clear cell stromal tumor of the lung. The diagnosis of these unusual neoplasms can be difficult, especially when dealing with small biopsy material or separating sarcomas from non-mesenchymal tumors with sarcomatoid morphology. Likewise, a metastatic process from a soft tissue primary should always be excluded before a diagnosis of primary pulmonary sarcoma can be confirmed. Fortunately, the increasing identification of distinct molecular aberrations in soft tissue, as well as pulmonary sarcomas, adds a significant diagnostic tool in this context. Since the treatment and prognosis for patients with pulmonary sarcomas varies greatly from those with bronchogenic carcinomas, comprehensive evaluation, to include immunohistochemical and molecular analysis, is not only essential for correct diagnosis, but also to predict patient outcome.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.